AVN soars 30% as we near Sept. 1st! -- Stock Picks

[ Show ]

Support VoyForums

[ Shrink ]

VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

[ Login ] [ Contact Forum Admin ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1, 2 ]

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Date Posted: 03:10:51 08/29/00 Tue
Author: AVN soars 30% as we near Sept. 1st!
Subject: AVN soars 30% as we near Sept. 1st!

AVN soars 30% as we near Sept. 1st!
AVN became a top gainer and advancer yesterday as it soared 30% on the AMEX.
It seemed as though shareholders were scrambling for shares before the opening of Xenerex, a newly formed division of AVN. Xenerex will open with the distinct goal of providing fully human monoclonal antibodies to Pharmacutical and Biotech companies worldwide.
AVN recently formed Xenerex to compete with high flyers such as ABGX & MEDX. Both ABGX and MEDX soared earlier this year based on technology similar to AVN's. ABGX went to 400+ in the bull market (before announcing 2 splits) and MEDX soared to 200+. AVN says Xenerex will open for business Sept. 1
and they are already in discussions with possible partners. In a recent interview, Gregory Hansen, Xenerex President is touting the Xenerex
mouse as having great advantages over the competition.

"Using immuno-deficient mice, rather than transgenic mice, Xenerex can produce completely human antibodies faster
and cheaper than its competition, big market players like Abgenix Inc., Medarex Inc. and Cambridge Antibody
Technology plc, Hansen said. "

Bioworld Online,
Aug 21, 2000

Also bear in mind that AVN will post profits next quarter due to the FDA approval of the first Over-The-Counter Herpes Cream.

http://biz.yahoo.com/p/a/avn.html

http://www.avanir.com/

[ Next Thread | Previous Thread | Next Message | Previous Message ]